[Hereditary hemochromatosis: the most frequent inherited human disease]

Katarzyna Sikorska1, Krzysztof Piotr Bielawski, Tomasz Romanowski

  • 1Klinika Chorób Zakaźnych Akademii Medycznej w Gdańsku.

Insights

Hereditary hemochromatosis, a common inherited iron overload disorder, results from gene mutations affecting iron metabolism. Early diagnosis and treatment are crucial to prevent severe organ damage and disease progression.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Hematology

Background:

  • Hereditary hemochromatosis is a prevalent inherited disorder in Caucasian populations.
  • It stems from genetic mutations impacting iron metabolism, leading to excessive iron absorption and accumulation.
  • This iron overload causes oxidative stress, cellular damage, inflammation, and fibrosis.

Purpose of the Study:

  • To describe the clinicopathology and genetic basis of hereditary hemochromatosis.
  • To outline the different forms of hemochromatosis and their distinct pathophysiology.
  • To emphasize the importance of early diagnostics for effective management.

Main Methods:

  • Review of genetic mutations affecting iron metabolism.
  • Analysis of iron absorption and macrophage recycling pathways.
  • Clinical and pathological characterization of hereditary hemochromatosis subtypes.

Main Results:

  • Mutations in iron metabolism genes cause progressive body iron accumulation.
  • Iron overload leads to oxidative stress, inflammation, fibrosis, and multiorgan damage.
  • Advanced stages may present with liver cirrhosis, cancer, diabetes, and cardiac issues.

Conclusions:

  • Hereditary hemochromatosis is a common genetic disorder with significant health consequences.
  • Understanding the distinct forms, including classical, juvenile, and ferroportin disease, is vital.
  • Prompt diagnosis enables early intervention, preventing disease progression and organ failure.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...